Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

Not Applicable

Completed

• Conditions: Overweight and Obesity

• Registration Number: NCT05451927
• Lead Sponsor: Hafiza Aisha Sadiqa

Brief Summary

This double-blind randomized placebo-controlled trial will test the hypothesis that administration of Phaseolus Vulgaris supplementation to women in Lahore, Pakistan, who are overweight will induce the weight loss (Primary outcome) and changes in body composition (Waist circumference) secondary outcome.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-07-01
• Study First Submitted QC: 2022-07-06
• Study First Posted: 2022-07-11
• Study Start: 2022-10-27
• Primary Completion: 2023-12-30
• Study Completion: 2023-12-30
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-28
• Last Update Posted: 2024-04-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

• BMI ranges from 25-40
• Consistently stable body weight for at least 6 months
• Good general health
• No ongoing drug treatment for weight reduction
• Commitment to avoid any changes in lifestyle throughout the test period
• Age between 18-45 years
• Women resident of Lahore

Exclusion Criteria

• Pregnant or breast-feeding females
• People with Type 2 diabetes
• People with any other chronic diseases
• Weight reduction treatment during the 6 months prior to the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Body weight	3 months	change in body weight

Trial Locations

Locations (2)

Akhuwat Medical Centre; 🇵🇰 Lahore, Punjab, Pakistan

Niazi Medical Centre; 🇵🇰 Lahore, Punjab, Pakistan